E135: IL17 and a GLP1?
Apr 30, 2026 - 11:03
Radio and PodcastLive Radio & PodcastsLoading episode
Fetching episode details...
Radio and PodcastLive Radio & PodcastsRadio and PodcastLive Radio & PodcastsFetching episode details...
Radio and PodcastLive Radio & PodcastsAnother day, another b cell podcast. Seems to be all the rage! This week I discuss the recently published NEJM trial of the anti CD20 agent obinutuzumab in lupus nephritis. Worth a read and listen, paper can be found her...
E121: Obinutuzumab in SLE-LN is an episode from The Evidence Based Rheumatology Podcast by Michael Putman. Another day, another b cell podcast. Seems to be all the rage! This week I discuss the recently published NEJM trial of the anti CD20...
This episode belongs to The Evidence Based Rheumatology Podcast.
Use the player on this page to stream the episode online.
Published Apr 2, 2025, 18:14 long, audio available.
Continue listening to more episodes from The Evidence Based Rheumatology Podcast.
Apr 30, 2026 - 11:03
Apr 17, 2026 - 14:58
Mar 19, 2026 - 15:21
Mar 5, 2026 - 13:54
Jan 21, 2026 - 14:48
Dec 22, 2025 - 13:06
Dec 4, 2025 - 15:17
Nov 12, 2025 - 19:03
Another day, another b cell podcast. Seems to be all the rage! This week I discuss the recently published NEJM trial of the anti CD20 agent obinutuzumab in lupus nephritis. Worth a read and listen, paper can be found here:
You can listen to E121: Obinutuzumab in SLE-LN online on Radio and Podcast. Open the player on this page to stream the available audio.
E121: Obinutuzumab in SLE-LN is an episode from The Evidence Based Rheumatology Podcast by Michael Putman.
This episode is 18:14 long.
This episode was published on Apr 2, 2025.
Yes. Use the heart button on the episode page to add it to your favorite episodes list.
Yes. This page shows related episodes from The Evidence Based Rheumatology Podcast when more episodes are available from the podcast feed.
You can listen to E121: Obinutuzumab in SLE-LN on this page when the episode audio is available from the podcast feed.
E121: Obinutuzumab in SLE-LN is from The Evidence Based Rheumatology Podcast by Michael Putman.
Published Apr 2, 2025 and 18:14 long